Citations

Showing 10 of 108104 citations.

Perinatal Nutritional Reprogramming of the Epigenome Promotes Subsequent Development of Nonalcoholic Steatohepatitis
Sanchez, Luz Helena Gutierrez , Tomita, Kyoko, Guo, Qianqian , Furuta, Kunimaro , Alhuwaish, Husam, Hirsova, Petra , Baheti, Saurabh , Alver, Bonnie, Hlady, Ryan A. , Robertson, Keith D. , Ibrahim, Samar H. , Sanchez, Luz Helena Gutierrez , Gutierrez Sanchez, Luz Helena, Hlady, Ryan , Hirsova, Petra , Robertson, Keith D , Ibrahim, Samar H , Guo, Qianqian , Gutierrez Sanchez, Luz Helena

Mayo Clinic

Hepatology Communications | October 2, 2018 | Volume: 2 | Issue: 12 | Pages: 1493-1512

10.1002/hep4.1265 | PMID 30556038 Get It

With the epidemic of obesity, nonalcoholic fatty liver disease (NAFLD) has become the most common pediatric liver disease. The influence of a perinatal obesity‐inducing diet (OID) on the development and progression of NAFLD in offspring is important but incompletely studied. Hence, we fed breeding pairs of C57BL/6J mice during gestation and lactation (perinatally) either chow or an OID rich in fat, fructose, and cholesterol (FFC). The offspring were weaned to either chow or an FFC diet, generating four groups: perinatal (p)Chow‐Chow, pChow‐FFC, pFFC‐Chow, and pFFC‐FFC. Mice were sacrificed at 10 weeks of age. We examined the whole‐liver transcriptome by RNA sequencing (RNA‐seq) and whole‐liver genome methylation by reduced representation bisulfite sequencing (RRBS). Our results indicated that the pFFC‐FFC mice had a significant increase in hepatic steatosis, injury, inflammation, and fibrosis, as assessed histologically and biochemically. We identified 189 genes that were differentially expressed and methylated in the pFFC‐FFC mice versus the pChow‐FFC mice. Gene set enrichment analysis identified hepatic fibrosis/hepatic stellate cell activation as the top canonical pathway, suggesting that the differential DNA methylation events in the mice exposed to the FFC diet perinatally were associated with a profibrogenic transcriptome. To verify that this finding was consistent with perinatal nutritional reprogramming of the methylome, we exposed pFFC‐Chow mice to an FFC diet in adulthood. These mice developed significant hepatic steatosis, injury, inflammation, and more importantly fibrosis when compared to the appropriate controls.Conclusion: Perinatal exposure to an OID primes the immature liver for an accentuated fibrosing nonalcoholic steatohepatitis (NASH) phenotype, likely through nutritional reprogramming of the offspring methylome. These data have potential clinical implications for monitoring children of obese mothers and risk stratification of children with NAFLD.
Reappraisal of Ischemic Heart Disease
Kaski, Juan‐Carlos, Camici, Paolo G. , Kaski, Juan Carlos , Crea, Filippo , Gersh, Bernard J.

Mayo Clinic

Circulation | October 1, 2018 | Volume: 138 | Issue: 14 | Pages: 1463-1480

10.1161/circulationaha.118.031373 | PMID 30354347 Get It

In recent years, it has become apparent that coronary microvascular dysfunction plays a pivotal pathogenic role in angina pectoris. Functional and structural mechanisms can affect the physiological function of the coronary microvasculature and lead to myocardial ischemia in people without coronary atheromatous disease and also in individuals with obstructive coronary artery disease. Abnormal dilatory responses of the coronary microvessels, coronary microvascular spasm, and extravascular compressive forces have been identified as pathogenic mechanisms in both chronic and acute forms of ischemic heart disease. The condition characterized by anginal symptoms and evidence of myocardial ischemia triggered by coronary microvascular dysfunction, in the absence of obstructive coronary disease, is known as microvascular angina. The concept of microvascular angina, however, may extend further to include patients with obstructive coronary artery disease and individuals with angina after coronary revascularization or heart transplantation because coronary microvascular dysfunction contributes to myocardial ischemia in many such patients. Patients with microvascular angina constitute a sizeable proportion of all cases of stable angina undergoing diagnostic coronary angiography and of those with persisting angina after successful coronary revascularization. Coronary microvascular dysfunction is also often responsible for angina in individuals with cardiomyopathy and heart valve disease as well as acute coronary syndrome cases such as Takotsubo syndrome and myocardial infarction with no obstructive coronary artery disease. Patients with stable microvascular angina present typically with effort or rest chest pain and a reduced coronary flow reserve or microvascular spasm. This condition, which affects women and men, can markedly impair quality of life and prognosis and represents a substantial cost burden to healthcare systems and individuals alike. In recent years, progress in the diagnosis of myocardial ischemia and the use of tests to investigate functional and structural causes for a reduced coronary flow reserve and microvascular spasm have allowed the identification of an increased number of cases of microvascular angina in everyday clinical practice. Although some of the available anti-anginal drugs may be helpful, treatment of coronary microvascular dysfunction remains a major challenge. The present article discusses the fundamental role that coronary microvascular dysfunction plays in the pathogenesis of ischemic heart disease, the clinical characteristics of patients presenting with microvascular angina, and possible diagnostic and therapeutic strategies.
Medical Parasitology Taxonomy Update, 2016–2017
Mathison, Blaine A. , Pritt, Bobbi S. , Pritt, Bobbi S , Mathison, Blaine A

Mayo Clinic

Journal of Clinical Microbiology | October 1, 2018 | Volume: 57 | Issue: 2 | Pages: No page available

10.1128/jcm.01067-18 | PMID 30282786 Get It

Parasite taxonomy continues to change as molecular and morphologic studies enhance our understanding of parasite relatedness. This minireview builds on the information provided in the last taxonomy update in this journal to summarize new and revised clinically relevant human parasite taxonomic changes that have occurred in 2016 and 2017.
Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia
Aypar, Umut , Smoley, Stephanie A., Pitel, Beth A. , Pearce, Kathryn E., Zenka, Roman M. , Vasmatzis, George , Johnson, Sarah H. , Smadbeck, James B. , Peterson, Jess F. , Geiersbach, Katherine B. , Dyke, Daniel L. Van , Thorland, Erik C., Jenkins, Robert B. , Greipp, Patricia T. , Kearney, Hutton M. , Hoppman, Nicole L., Van Dyke, Daniel L, Peterson, Jess F , Pitel, Beth A , Greipp, Patricia T , Ketterling, Rhett P. , Baughn, Linda B. , Aypar, Umut , Geiersbach, Katherine

Mayo Clinic

European Journal of Haematology | October 1, 2018 | Volume: 102 | Issue: 1 | Pages: 87-96

10.1111/ejh.13179 | PMID 30270457 Get It

AbstractObjectiveAcute myeloid leukemia (AML) can be subtyped based on recurrent cytogenetic and molecular genetic abnormalities with diagnostic and prognostic significance. Although cytogenetic characterization classically involves conventional chromosome and/or fluorescence in situ hybridization (FISH) assays, limitations of these techniques include poor resolution and the inability to precisely identify breakpoints.MethodWe evaluated whether an NGS‐based methodology that detects structural abnormalities and copy number changes using mate pair sequencing (MPseq) can enhance the diagnostic yield for patients with AML.ResultsUsing 68 known abnormal and 20 karyotypically normal AML samples, each recurrent primary AML‐specific abnormality previously identified in the abnormal samples was confirmed using MPseq. Importantly, in eight cases with abnormalities that could not be resolved by conventional cytogenetic studies, MPseq was utilized to molecularly define eight recurrent AML‐fusion events. In addition, MPseq uncovered two cryptic abnormalities that were missed by conventional cytogenetic studies. Thus, MPseq improved the diagnostic yield in the detection of AML‐specific structural rearrangements in 10/88 (11%) of cases analyzed.ConclusionUtilization of MPseq represents a precise, molecular‐based technique that can be used as an alternative to conventional cytogenetic studies for newly diagnosed AML patients with the potential to revolutionize the diagnosis of hematologic malignancies.
Awake-craniotomy for cavernoma resection
Pamias-Portalatin, Eva, Durán, Iván Segura, Ebot, James , Bojaxhi, Elird , Tatum, William O. , Quiñones‐Hinojosa, Alfredo

Mayo Clinic

Neurosurgical Focus | October 1, 2018 | Volume: 45 | Issue: VideoSuppl2 | Pages: V3

10.3171/2018.10.focusvid.18201 | PMID 30269557 Get It

Cavernomas make up approximately 8%–15% of all intracranial vascular malformations, and the most common presenting symptom is seizures. Complete resection of the cavernoma and removal of the surrounding gliotic core presents a cure but poses a challenge if an eloquent brain is involved or with incomplete resection of the epileptogenic foci. The authors present the case of a 53-year-old man with intractable seizures from a left posterior temporal lobe cavernoma who underwent an awake craniotomy with intraoperative seizure monitoring via electrocorticography. The video can be found here: https://youtu.be/vxaikozg2g4 .
Decisional regret in women receiving high risk or inconclusive prenatal cell-free DNA screening results
Gammon, Betsy L., Jaramillo, Carolina, Riggan, Kirsten A. , Allyse, Megan , Allyse, Megan A , Riggan, Kirsten A

Mayo Clinic

The Journal of Maternal-Fetal & Neonatal Medicine | October 1, 2018 | Volume: No volume available | Issue: No issue available | Pages: 1-7

10.1080/14767058.2018.1519541 | PMID 30269633 Get It

Mitochondria
Dzeja, Petras P. , Özcan, Cevher , Pucar, Darko , Holmuhamedov, Ekhson , Jahangir, Arshad , Terzic, André

Mayo Clinic

Circulation Research | September 30, 2018 | Volume: 89 | Issue: 9 | Pages: 744-746

10.1161/res.89.9.744 Get It

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
Agasthi, Pradyumna , Narayanasamy, Hemalatha , Sorajja, Dan , Slack, James L., Mookadam, Farouk , Slack, James

Mayo Clinic

Case Reports in Cardiology | September 30, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-4

10.1155/2018/3953579 | PMID 30363961 Get It

Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic myelogenous leukemia, and acute myelogenous leukemia. We present a case of cardiomyopathy associated with decitabine used for secondary acute myelogenous leukemia. The patient presented with new heart failure symptoms and an ejection fraction decline.
Cardiac Sodium Channel Gene Mutations and Sudden Infant Death Syndrome
Towbin, Jeffrey A. , Ackerman, Michael J.

Mayo Clinic

Circulation | September 30, 2018 | Volume: 104 | Issue: 10 | Pages: 1092-1093

10.1161/circ.104.10.1092 Get It

Incidence and outcomes of early percutaneous coronary intervention after isolated valve surgery
Ziada, Khaled M. , Rihal, Charanjit S. , Alkhouli, Mohamad , Ziada, Khaled , Alkhouli, Mohamad , Alqahtani, Fahad , Rihal, Charanjit S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | September 30, 2018 | Volume: 93 | Issue: 4 | Pages: 583-589

10.1002/ccd.27874 | PMID 30269409 Get It

AbstractBackgroundCoronary ischemia requiring early percutaneous coronary intervention (PCI) is a rare but serious complication of isolated valve surgery. We sought of assess the incidence, predictors and outcomes of early PCI after isolated valve surgery using the national inpatient sample.MethodsPatients who underwent isolated aortic valve replacement (AVR), isolated mitral valve repair (MVr) or replacement (MVR) between 2003 and 2014 were identified. Patients who had early postoperative PCI were compared with patients who did not require PCI. Primary end point was in‐hospital mortality. Secondary endpoints were complications, length‐of‐stay and cost.ResultsAmong the 135,611 included patients, 1,074 (0.8%) underwent PCI prior to discharge. Unadjusted in‐hospital mortality was higher in patients requiring early PCI following AVR (11.2 vs. 3.1%), MVR (24.1 vs. 5.5%), and MVr (22.4 vs. 2.5%) (P < 0.001) compared with patients not requiring PCI. Postoperative PCI remained independently associated with higher mortality after adjusting for demographics, comorbidities and hospital characteristics (adjusted OR [aOR] = 3.74, 95%CI 2.70–5.17 for AVR, aOR = 6.10, 95%CI 4.53–8.23 for MVR, and aOR = 9.90, 95%CI 7.22–13.58 for MVr). Patients undergoing PCI had higher incidences of stroke, acute kidney injury, infectious complications, higher hospital charges, and longer hospitalizations. Age, robotic‐assisted surgery, and chronic renal failure were independent predictors of needing early postoperative PCI.ConclusionsEarly PCI after isolated aortic or mitral valve surgery is rare but is associated with substantial in‐hospital morbidity, mortality, and cost. Further studies are needed to identify preventable causes, and optimal management strategies of this serious complication.